» Articles » PMID: 11788582

YB-1 Relocates to the Nucleus in Adenovirus-infected Cells and Facilitates Viral Replication by Inducing E2 Gene Expression Through the E2 Late Promoter

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Jan 15
PMID 11788582
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

The adenovirus early proteins E1A and E1B-55kDa are key regulators of viral DNA replication, and it was thought that targeting of p53 by E1B-55kDa is essential for this process. Here we have identified a previously unrecognized function of E1B for adenovirus replication. We found that E1B-55kDa is involved in targeting the transcription factor YB-1 to the nuclei of adenovirus type 5-infected cells where it is associated with viral inclusion bodies believed to be sites of viral transcription and replication. We show that YB-1 facilitates E2 gene expression through the E2 late promoter thus controlling E2 gene activity at later stages of infection. The role of YB-1 for adenovirus replication was demonstrated with an E1-minus adenovirus vector containing a YB-1 transgene. In infected cells, AdYB-1 efficiently replicated and produced infectious progeny particles. Thus, adenovirus E1B-55kDa protein and the host cell factor YB-1 act jointly to facilitate adenovirus replication in the late phase of infection.

Citing Articles

YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells.

von Ofen A, Thiel U, Eck J, Gassmann H, Thiede M, Hauer J Front Oncol. 2024; 14:1304374.

PMID: 38357194 PMC: 10865101. DOI: 10.3389/fonc.2024.1304374.


Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential.

Dinh N, Nguyen T, Park M, Lee C Int J Mol Sci. 2024; 25(2).

PMID: 38255791 PMC: 10815159. DOI: 10.3390/ijms25020717.


The adenovirus DNA-binding protein DBP.

Bertzbach L, Seddar L, von Stromberg K, Ip W, Dobner T, Hidalgo P J Virol. 2024; 98(2):e0188523.

PMID: 38197632 PMC: 10878046. DOI: 10.1128/jvi.01885-23.


Development of an optimized, non-stem cell line for intranasal delivery of therapeutic cargo to the central nervous system.

El-Ayoubi A, Arakelyan A, Klawitter M, Merk L, Hakobyan S, Gonzalez-Menendez I Mol Oncol. 2023; 18(3):528-546.

PMID: 38115217 PMC: 10920084. DOI: 10.1002/1878-0261.13569.


Targeting Cell Cycle Facilitates E1A-Independent Adenoviral Replication.

Ehrenfeld M, Segeth F, Mantwill K, Brockhaus C, Zhao Y, Ploner C J Virol. 2023; 97(6):e0037023.

PMID: 37219458 PMC: 10308897. DOI: 10.1128/jvi.00370-23.